D-PLEX 311- Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-PLEX In Prevention of Post Abdominal Surgery Incisional Infection(SHIELD I)
Latest Information Update: 23 Oct 2024
At a glance
- Drugs Doxycycline hyclate (Primary) ; Antibacterials
- Indications Surgical wound infections
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms SHIELD I
- Sponsors POLYPID
- 21 Oct 2024 According to a POLYPID media release, today announced a publication in the International Journal of Surgery (IJS), the article highlights the full dataset from the first Phase 3 study of D-PLEX100, from which top-line results were announced in September 2022.
- 09 Oct 2023 According to a POLYPID media release, data from this study will be presented at the American College of Surgeons Clinical Congress 2023.
- 12 Dec 2022 According to POLYPID media release, the company provided the FDA with currently available data from this study.